The many issues preventing patients in remote indigenous communities from receiving optimal health care are longstanding and complex; I am happy to be able to do my part to start working towards solutions.
COVID-19 vaccines were approved for children 5 to 12 earlier this year, but provinces have been slower to roll-out in-pharmacy vaccinations for children.
This second article in a series from a pharmacist and certified MS specialist helps explains how to differentiate this complex and often misunderstood disease from other conditions.